XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income (loss) $ (80,582) $ 62,542 $ 9,517
Adjustments to reconcile net income to net cash provided by operating acitivites:      
Depreciation 16,055 16,494 18,044
Amortization of Debt Discount 0 10,217 9,692
Amortization of Deferred Debt Issuance Costs 4,910 3,726 3,723
Amortization 53,464 54,249 54,581
Stock-based compensation 21,729 16,335 13,111
Deferred income taxes (6,042) 3,005 (14,234)
Non-cash adjustment to fair value of contingent consideration liability 2,518 0 0
Write off of Deferred Debt Issuance Cost 3,426 899 0
Loss on convertible notes conversion premium 103,125 0 0
Loss on convertible notes hedge transactions settlement 5,460 0 0
Increase (decrease) in cash flows from changes in assets and liabilities, net of acquired assets      
Accounts receivable (5,203) (9,159) 13,920
Inventories (78,564) (37,806) (30,397)
Accounts payable 13,302 4,890 (2,977)
Income taxes 6,726 (1,675) (1,644)
Accrued compensation and benefits (8,968) 11,067 (4,123)
Other assets (17,735) (24,005) (8,170)
Other liabilities (256) 991 3,488
Net cash provided by operating activities 33,365 111,770 64,531
Cash flows from investing activities:      
Purchases of property, plant and equipment (21,785) (14,866) (13,013)
Payments related to business acquisitions and asset acquisitions, net of cash acquired (227,744) 0 (3,852)
Proceeds from Sale of Property Held-for-sale 0 0 3,227
Net cash used in investing activities (249,529) (14,866) (13,638)
Cash flows from financing activities:      
Payments on term loan (92,981) (66,654) (13,250)
Proceeds from term loan 0 52,411 0
Payments on revolving line of credit (530,000) (393,753) (212,000)
Proceeds from revolving line of credit 460,000 326,753 199,000
Payments to redeem convertible notes (275,000) 0 0
Proceeds from Convertible Debt 800,000 0 0
Payments Related to Contingent Consideration (798) (6,222) (2,671)
Payments related to debt issuance costs (21,830) (2,000) (3,153)
Dividends paid on common stock (23,960) (23,256) (22,818)
Purchase of Convertible Notes Hedges (187,600) 0 0
Proceeds from Issuance of Warrants 72,000 0 0
Proceeds from settlement of convertible notes hedge transactions 86,228 0 0
Payment for settlement of warrants (69,534) 0 0
Other, net 8,475 11,173 2,833
Net cash provided by (used in) financing activities 225,000 (101,548) (52,059)
Effect of exchange rate changes on cash and cash equivalents (741) (1,865) 2,666
Net increase (decrease) in cash and cash equivalents 8,095 (6,509) 1,500
Cash and cash equivalents at beginning of year 20,847 27,356 25,856
Cash and cash equivalents at end of year 28,942 20,847 27,356
Non-cash investing and financing activities:      
Contingent consideration 183,914 0 0
Dividends payable 6,098 5,874 5,775
Cash paid during the year for:      
Interest 26,081 21,797 30,448
Income taxes $ 9,074 $ 8,559 $ 9,120